Expertise

• anti-competitive behavior in health care markets
• economic assessment of mental health interventions
• conjoint analysis of patient treatment preferences
• econometric evaluation of real-world treatment effects
• health economics
• pharmaceutical economics
• HIV/AIDS medical costs and
  epidemiology
• health insurance reform
• cost/benefit analysis, and comparative effectiveness research
• economic assessment of medical
  technology and medical interventions
• public policy issues relating to substance
  abuse
• socioeconomic costs of drug and alcohol
  abuse — the harm users do to others
• drug legalization — arguments pro and
  con

Additional Information

• Founding Editor-in-Chief of Value in Health, journal of International Society for Pharmacoeconomics and Outcomes Research
• Author of Health Care in Hong Kong: An Economic Policy Assessment (1992)
• Author of numerous health-related op-ed pieces published in The Wall Street Journal, San Francisco Chronicle, U-T San Diego, Newsday and The Sacramento Bee
• Consultant to U.S. Centers for Medicare and Medicaid Services, U.S. Agency for Health Care Research and Quality, U.S. Centers for Disease Control, U.S. Public Health Service, U.S. Food and Drug Administration, U.S. Environmental Protection Agency, U.S. National Institutes of Health, U.S. National Science Foundation, U.S. Congressional Budget Office, National Association of Attorneys General, California AIDS Leadership Commission, Netherlands Organization for Health Research and Development, Hong Kong Hospital Authority, Hungarian Parliament, and Rand Corporation

Videos

• Insurance Innovation: How to Succeed after Reform -- and Repeal (Joel Hay) January 24, 2011
• Insurance Innovation: How to Succeed after Reform -- and Repeal (Joel Hay)

Related links

• Pharmacy profile
• Schaeffer profile

Related faculty

• Dana Goldman
• Jeffrey S. McCombs
• Neeraj Sood

Tags